ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Immunosuppression"

  • 2017 American Transplant Congress

    In Vitro Optimisation of the Immunotherapeutic Effects of Umbilical Cord Derived MSC.

    S. de Witte,1 A. Merino,1 M. Franquesa,1 T. Strini,1 J. van Zoggel,1 S. Korevaar,1 F. Luk,1 M. Gargesha,4 D. Roy,4 S. Elliman,2 P. Newsome,3 C. Baan,1 M. Hoogduijn.1

    1Department of Internal Medicine, ErasmusMC, Rotterdam, Netherlands; 2Orbsen Therapeutics Ltd., Galway, Ireland; 3Department of NIHR Liver Biomedical Research Unit and Centre for Liver Research, University of Birmingham, Birmingham, United Kingdom; 4BioInVision Inc., Mayfield Village

    Mesenchymal stromal cells (MSC) possess immunomodulatory properties and are low immunogenic, which are both important for their development into an effective cellular immunotherapy after organ…
  • 2017 American Transplant Congress

    Population Pharmacokinetic Profiling of Tacrolimus in Renal Transplant Recipients (RTRs) Taking Diltiazem.

    P. Trevillian,1,2,3 M. Heer,1,2 S. Ainsworth,1 A. Hibberd.1,2,3

    1Newcastle Transplant Unit, John Hunter Hospital, Newcastle, NSW, Australia; 2University of Newcastle, Newcastle, NSW, Australia; 3Hunter Transplant Research Foundation, Hunter Medical Research Institute, Newcastle, NSW, Australia

    Background: Over the past 6 years we have prospectively used pharmacokinetic (PK) profiling of Tacrolimus (TAC) in “stable” RTR's to individualise future dosing. This study…
  • 2017 American Transplant Congress

    Risks Associated with Recombinant IL2 Therapy in Renal Transplantation.

    M. McGrath, S. Tripathi, A. Chandraker.

    Brigham and Women's Hospital, Boston

    Regulatory T cells are critical to allograft survival. We report a pilot study of safety and tolerability of low dose recombinant IL2 (rIL2), 1x106 units/m2/day…
  • 2017 American Transplant Congress

    National Variation in Liver Transplant Immunosuppression in the U.S..

    M. Nazzal,1 R. Ouseph,1 M. Schnitzler,1 Z. Zhang,1 D. Axelrod,2 D. Segev,3 A. Naik,4 H. Randall,1 D. Brennan,5 B. Kasiske,6 G. Hess,7 T. Alhamad,5 K. Lentine.1

    1St Louis Univ, St Louis; 2E Carolina Univ, Greenville; 3Johns Hopkins, Baltimore; 4U Michigan, Ann Arbor; 5Washington Univ, St Louis; 6SRTR, Minneapolis; 7Symphony Health, Philadelphia

    Variation in immunosuppression (ISx) for liver transplant (LTx) across US programs has not been described. We examined a novel database integrating national registry and pharmacy…
  • 2017 American Transplant Congress

    A Search for a Biomarker Which Predicts Belatacept-Resistant Rejection.

    G. de Graav,1 C. Baan,1 M. Clahsen-van Groningen,2 R. Kraaijeveld,1 M. Dieterich,1 W. Verschoor,1 D. Roelen,3 M. Cadogan,1 J. van de Wetering,1 J. van Rosmalen,4 W. Weimar,1 D. Hesselink.1

    1Internal Medicine, Erasmus University Medical Center, Rotterdam, South Holland, Netherlands; 2Pathology, Erasmus University Medical Center, Rotterdam, South Holland, Netherlands; 3Immunohematology and Blood Transfusion, Erasmus University Medical Center, Rotterdam, South Holland, Netherlands; 4Biostatistics, Erasmus University Medical Center, Rotterdam, South Holland, Netherlands

    Belatacept, an inhibitor of the CD28-CD80/86 costimulatory pathway, has been associated with a higher acute rejection risk than ciclosporin. We sought to identify a biomarker…
  • 2017 American Transplant Congress

    The Associations Between Body Mass Index and Kidney Transplant Outcomes Are Mediated by Weight-Adjusted Immunosuppression Dosing.

    K. Flabouris,1,2 S. Chadban,1,3,4 M. Ladhani,1,3,5 M. Cervelli,6 P. Clayton.1,2,6

    1Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, Adelaide, Australia; 2School of Medicine, University of Adelaide, Adelaide, Australia; 3Sydney Medical School, University of Sydney, Sydney, Australia; 4Department of Renal Medicine, Royal Prince Alfred Hospital, Sydney, Australia; 5Department of Renal Medicine, Lyell McEwin Hospital, Adelaide, Australia; 6Central Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, Australia

    Purpose: High body mass index (BMI) is associated with acute rejection after kidney transplantation. We hypothesised that weight-adjusted immunosuppression dosing is a contributing factor. We…
  • 2017 American Transplant Congress

    Rituximab Desensitization (DES) and Alemtuzumab Induction Significantly Reduced EBV Viremia and Post-Transplant Lymphoproliferative Disorder (PTLD) in HLA-Sensitized (HS) Kidney Transplant Patients.

    B.-H. Shin,1 S. Ge,1 J. Mirocha,2 D. Thomas,1 E. Rodriguez,1 C. Chao,1 O. Galera,1 A. Vo,1 J. Choi,1 A. Peng,1 J. Kahwaji,1 S. Jordan,1 M. Toyoda.1

    1Transplant Immunology Laboratory and Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA; 2Biostatistics Core, Cedars-Sinai Medical Center/UCLA School of Medicine, Los Angeles, CA

    Background: PTLD is a serious complication in KTx pts and is usually associated with EBV infection. Recent studies showed that rituximab treatment prior to Tx…
  • 2017 American Transplant Congress

    Tacrolimus and Mycophenolic Acid Have a Limited Inhibitory Effect on Monocyte Signaling Pathway Phosphorylation, Function and Differentiation.

    N. Kannegieter,1 D. Hesselink,1 M. Dieterich,1 R. Kraaijeveld,1 A. Rowshani,1 P. Leenen,2 C. Baan.1

    1Internal Medicine, Erasmus MC, Rotterdam, Netherlands; 2Immunology, Erasmus MC, Rotterdam, Netherlands

    Introduction Monocytes and macrophages play key roles in cellular and humoral rejection after solid organ transplantation, but little is known about the effects of the…
  • 2017 American Transplant Congress

    The Inhibitory Effect of Plasma on T Cell Activation: Possible Role of Plasma Exchange in Anti Rejection Therapy.

    A. Assounga,1,2 S. Omarjee.1

    1Dept Nephrology, University of KwaZulu-Natal, Durban, South Africa; 2Inkosi Albert Luthuli Central Hospital, Durban, South Africa

    Reduction of lymphocyte proliferation by human plasma has been previously reported. Reduced activation of lymphocytes of patients on immunosuppressive drugs is well documented.Aim: To compare…
  • 2017 American Transplant Congress

    Clinical Outcomes of Kidney Transplant Recipients by Steroid Early Withdraw Protocol with Basiliximab Induction.

    Y. Takada, K. Hotta, D. Iwami, H. Higuchi, T. Hirose, H. Sasaki, N. Shinohara.

    Urology, Hokkaido University Hospital, Sapporo, Japan

    [Purpose] Several steroid early withdrawal protocols (SEWD) have been attempted in recent decades to avoid steroid related adverse effects among kidney transplant recipients. However, there…
  • « Previous Page
  • 1
  • …
  • 85
  • 86
  • 87
  • 88
  • 89
  • …
  • 138
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences